Professional Documents
Culture Documents
Marciniak 2020
Marciniak 2020
Marciniak 2020
Rafał Marciniak 1,2 Background: Mindfulness-based programs have shown a promising effect on several health
Rastislav Šumec 1,3,4 factors associated with increased risk of dementia and the conversion from mild cognitive
For personal use only.
Martin Vyhnálek 1 impairment (MCI) to dementia such as depression, stress, cognitive decline, immune system
Kamila Bendíčková 5 and brain structural and functional changes. Studies on mindfulness in MCI subjects are
sparse and frequently lack control intervention groups.
Petra Lázničková 5,6
Objective: To determine the feasibility and the effect of mindfulness-based stress reduction
Giancarlo Forte 5
(MBSR) practice on depression, cognition and immunity in MCI compared to cognitive
Andrej Jeleník 1
training.
Veronika Římalová 1,7 Methods: Twenty-eight MCI subjects were randomly assigned to two groups. MBSR group
Jan Frič 5 underwent 8-week MBSR program. Control group underwent 8-week cognitive training.
Jakub Hort 1 Their cognitive and immunological profiles and level of depressive symptoms were exam
Kateřina Sheardová 1,3 ined at baseline, after each 8-week intervention (visit 2, V2) and six months after each
1
International Clinical Research Center intervention (visit 3, V3). MBSR participants completed feasibility questionnaire at V2.
(ICRC), St. Anne’s University Hospital, Results: Twenty MCI patients completed the study (MBSR group n=12, control group n=8).
Brno, Czech Republic; 2Department of
MBSR group showed significant reduction in depressive symptoms at both V2 (p=0.03) and
Psychology, Faculty of Social Studies,
Masaryk University, Brno, Czech Republic; V3 (p=0.0461) compared to the baseline. There was a minimal effect on cognition – a group
3
First Department of Neurology, Faculty of comparison analysis showed better psychomotor speed in the MBSR group compared to the
Medicine, Masaryk University and
St. Anne’s University Hospital, Brno, Czech control group at V2 (p=0.0493) but not at V3. There was a detectable change in immuno
Republic; 4Department of Psychology and logical profiles in both groups, more pronounced in the MBSR group. Participants checked
Psychosomatics, Faculty of Medicine, only positive/neutral answers concerning the attractivity/length of MBSR intervention. More
Masaryk University, Brno, Czech Republic;
5
Center of Translational Medicine, severe cognitive decline (PVLT≤36) was associated with the lower adherence to home
International Clinical Research Center practice.
(ICRC), St. Anne’s University Hospital,
Conclusion: MBSR is well-accepted potentially promising intervention with positive effect
Brno, Czech Republic; 6Department of
Biology, Faculty of Medicine, Masaryk on cognition, depressive symptoms and immunological profile.
University, Brno, Czech Republic; Keywords: cognition, depression, anxiety, MCI, neurodegeneration, monocyte activation
7
Department of Mathematical Analysis and
Applications of Mathematics, Faculty of
Science, Palacky University Olomouc,
Olomouc, Czech Republic Introduction
The number of people suffering from dementia is growing every year due to the
Correspondence: Rafał Marciniak increasing age of the world’s population. The number of patients with dementia is
International Clinical Research Center expected to double every 20 years.1 The dementia stage of Alzheimer’s disease
(ICRC), St. Anne’s University Hospital,
Pekařská 53, Brno 656 91, Czech (AD) is preceded by a prodromal stage referred to as mild cognitive impairment
Republic
Tel +420 736432470
(MCI),2 which is characterized by a measurable decline of cognition, but preserved
Email rafal.marciniaq@gmail.com activities of daily living. Besides the cognitive symptoms, MCI patients often
submit your manuscript | www.dovepress.com Clinical Interventions in Aging 2020:15 1365–1381 1365
DovePress © 2020 Marciniak et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/
http://doi.org/10.2147/CIA.S249196
terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing
the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
manifest neuropsychiatric symptoms (NPS) such as many other Mindfulness-Based Programs (MBPs) have
depression and anxiety or apathy and irritability.3,4 The been developed.35
presence of NPS increases the probability of converting MBSR studies with healthy elderly have shown
to AD dementia.5 Advanced age is commonly accompa a significant increase in physical health perception and
nied by chronic low-grade inflammation, which is also decreased depressive symptoms.36–39 Others have shown
present in the central nervous system6,7 and which con improvement in long-term memory and in attention and
tributes to many age-related disorders, including cognitive working memory,40 as well as in cognitive functions
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
dysfunctions and AD.8–10 Neurodegenerative disorders are generally.41 The long-term effect of MBSR might depend
associated with the early onset of immunosenescence,8,11 on the levels of continued meditation practice.42
manifesting via increased numbers of senescent T cells, MBPs may reduce chronic inflammation43 via changes of
increased levels of inflammatory cytokines, mainly CRP, inflammatory genes’ expression in peripheral blood mono
IL-6 and TNF, and also via changes in myeloid cells, nuclear cells (PBMCs) and via reduction of pro-
which has been reported in MCI,12,13 as well as in AD inflammatory markers and an increase of cell-mediated
dementia.14,15 immune and anti-aging response.44 The ability of MBSR to
Despite the fact that a lot of research has been focused change the levels of inflammatory cytokines has been also
on treatment strategies and many clinical trials with dis reported.37 Monocytes are perceived as the central sensors
ease-modifying drugs are currently under way, there is no and regulators of inflammation. The dysregulation of their
known effective treatment option that can stop or even phenotype and function has already been linked with
For personal use only.
having a positive effect on physical and mental health.53–55 symptoms as assessed by the Geriatric Depression Scale
One study examining the effect of Kirtan Kriya meditation (GDS) with a score above 10 points or a presence of
suggests only a marginal role being played by spiritual psychiatric disorders that may affect cognitive functions.
level in influencing cognition.56 Nevertheless, higher One hundred and nine subjects with MCI from the
levels of spirituality have been associated with a slower Czech Brain Aging study were invited randomly over the
rate of cognitive decline in patients with AD57 and in the phone to participate in this study, 28 participants accepted
healthy elderly.58,59 Therefore, spiritual well-being could the invitation and entered the study (Figure 1). The parti
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
potentially work as a mediator of the MBSR effect, espe cipants were assigned to one of the two groups according
cially on depressive symptoms and anxiety. to the sequence of entering the study in a ratio 2:1 (MBSR
The aim of this study was to explore the feasibility and group:Control group). The MBSR group (n=18) under
effect of MBSR compared to standard cognitive training: went an 8-week MBSR course, while the control group
(1) on cognitive functions (2) on depressive symptoms and (n=10) underwent cognitive training. The distribution was
anxiety and (3) on the immunophenotype of peripheral based on the order of entry into the study – after assigning
blood monocyte subsets, the plasma level of inflammatory two patients to the MBSR group, one was assigned to the
mediators and phagocytic activity and compare it with the control group and so on. The order of contacting the
effects of cognitive training as an active control. Thus, the potential participants was random. Based on our knowl
effect of MBSR on cognition, depressive/anxiety symp edge on good adherence in cognitive training
toms and immunological profile represent primary out interventions62–64 and a higher probability of drop out
For personal use only.
come variables. Moreover, we analyzed feasibility for from the more challenging MBSR intervention49 we
this intervention group and explored whether the number decided to create a larger MBSR group.
of post-intervention practice days or level of spiritual well-
being affects the effect of MBSR – these were secondary Assessment
outcome variables. We also tried to prevent the limitations The local St. Anne’s University Hospital Institutional
of previous studies such as a missing control intervention Review Board reviewed the entire protocol and agreed
group and in order to diminish the learning effect, we used that all procedures were done in accordance with the ethical
cognitive tests suitable for the MCI population like standards of the Committee on Human Experimentation of
Cogstate test battery.60 this institution and the study was conducted in accordance
Based on our previous knowledge and theoretical mod with the Declaration of Helsinki. Written informed consent
els, we hypothesized that although MBSR contrary to was obtained at the beginning. The scientific board of The
cognitive training is not a primary cognitive intervention, Alzheimer Foundation in the Czech Republic approved the
it will influence slow cognitive decline comparably to study’s description with outcome variables and the entire
standard cognitive training and through its brain mainte protocol specification. Participants’ cognitive functions,
nance mechanism, also influence NPS and favorably depressive symptoms and anxiety were measured at base
change immunological profile resulting in a reduction of line, at visit 2 (V2) – immediately after the 8-week inter
systemic inflammation. vention and at visit 3 (V3) – 6 months after the intervention.
Immunological parameters were measured at baseline and
at V2.
Materials and Methods
Study Participants Interventions
This interventional case-control study was conducted at MBSR Intervention
St. Anne’s University Hospital in Brno, Czech Republic. Participants in the MBSR group completed an 8-week-
Participants were selected from the Czech Brain Aging long MBSR intervention based on the authorized curricu
Study, which is a longitudinal study on aging with bio lum Guide.65 MBSR was administered by trained and
markers of AD.61 The inclusion criteria were: (1) certified instructor. The intervention began first with the
a diagnosis of MCI, based on Petersen16 criteria assessed “introduction to mindfulness” session, followed by
by a consensual MRI evaluation of the brain, 8 weekly sessions (2.5 hours long) and 1 “retreat in
a neurological and a neuropsychological examination, (2) silence” day (6 hours long). Each week, participants
age 55+ years. Exclusion criteria: high levels of depressive were given materials for home practice. Mindfulness was
cultivated through both formal (body scan, sitting medita guided audio recordings. The mindful movement sequence
tion, mindful movement, working with difficulties, medi was adapted to the patients’ physical limitations – specific
tation with imagination, etc.) and informal practices recordings guiding participants through more gentle move
(bringing mindfulness to routine activities, including ments were prepared. Besides, the length of formal prac
short breathing meditation, an analysis of pleasant and tices such as sitting meditation, mindful movement and
unpleasant events and stressful communication, etc.). body scan were shortened from 45 to 30 minutes, in
Home practice (30–50 minutes daily) was practised by agreement with the previous study.49
Cognitive Training values to z-scores and then averaging the tests. The same
Participants in the control group underwent cognitive procedure with the Stroop test and COWAT–FAS was
training – an active intervention that has been reported to chosen to create an “Executive function” domain. All
produce moderate-to-large beneficial effects on memory tests were designed for repeated administration with mini
and executive functions.66,67 While cognitive training is mal practice or learning effects, so we could use them
a method that tries to compensate for the loss of cognitive repeatedly throughout the study. The psycho-cognitive
functions without influencing the AD pathophysiological scales were administered by two blinded raters.
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
training. All exercises were taken from popular literature by the participant in the past month. Scores of 0–21
on cognitive exercises to the elderly.68–70 It contained indicate low anxiety, 22–35 indicate moderate anxiety,
exercises such as recognition of well-known melodies, scores of 36 and above indicate potentially concerning
line-ups of movie couples, recognizing minor changes in levels of anxiety. Both questionnaires were validated
the room, the Match Match card game, collectively creat with good psychometric properties.71,72
ing a story, Word Chain, etc. The time range of cognitive
training (group and home practicing) corresponded to the Immunophenotyping
MBSR time range and the control group members received Peripheral blood monocytes (PBMCs) from baseline and
as much support and attention as members of the MBSR V2 were isolated from 10 mL of non-coagulated blood by
group. After finishing their 8-week training, participants gradient centrifugation using Lymphoprep (density 1.077
were instructed to continue in their cognitive tasks and g/mL; STEMCELL technologies) following the manufac
they continued to obtain additional cognitive training turer’s recommendations. All blood samples were drawn
materials for the next 6 months. before administration of psycho-cognitive scales between
7–10 AM. Isolated PBMCs were cryopreserved using 10%
Primary Outcomes fetal bovine serum in DMSO and stored in liquid nitrogen
Cognitive Assessment for further batch FACS analysis. The thawed cells were
To measure cognitive performance, 3 paper-and-pen stained using lineage antibodies (anti-CD3-biotin, anti-
tests – the Stroop test,71 the Philadelphia Verbal Learning CD19-biotin, CD20-biotin, CD56-biotin, CD66b-biotin,
Test (PVLT),72 and the Controlled Oral Word Association CD235α-biotin followed by streptavidin eFluor405 stain
Test (COWAT-FAS)73 and 4 computer Cogstate tests60 ing), anti-CD45-PerCPeFluor710, anti-CD14-eFluor506,
were administered. The tests captured performance in dif anti-CD16-APC, anti-CD86-PE anti-HLA-DR-FITC (all
ferent cognitive domains: attention (the Cogstate eBiosciences). A LIVE/DEAD Fixable Near-IR Dead
Identification Test), psychomotor speed (the Cogstate Cell Stain Kit (ThermoFisher Scientific) was used to
Detection Test), visual learning (the Cogstate One Card exclude dead cells from the analysis. Lin− CD45+ leuco
Learning Test) and working memory (the Cogstate One cytes were classified into three monocyte subsets based on
Back Test), memory (PVLT), and executive functions (the the expression of CD14 and CD16 – classical (CD14+
+
Stroop test and COWAT – FAS). The sum of recalled CD16−), intermediate (CD14++CD16+) and non-classical
words over 5 learning trials and the number of words (CD14dimCD16++).76 Sample acquisition was performed
recalled after a 20-minute delay in PVLT were combined using FACS Canto II (BD Biosciences) and data were
into a “Memory score” domain through converting the analyzed using FlowJo v.10 (Tree Star).
Phagocytosis Assay daily (mindful eating, body scan, etc.). They were distrib
The pHrodo Green S. aureus BioParticles Phagocytosis uted a simple diary with all the options of mindful prac
Kit for Flow Cytometry (Invitrogen) was used according tices and they were asked to tick the practice they
to the manufacturer’s recommendations for detecting pha performed each day. The diary was later analyzed and
gocytic activity in fresh whole blood samples. Sample used as an intervening variable for making the analysis.
acquisition was performed via FACS Canto II (BD
Biosciences) and data were analyzed using FlowJo v.10 Statistical Analysis
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
(Tree Star). To compare the values at all three time points within each
Plasma Analysis – Enzyme-Linked Immunosorbent group, the Wilcoxon test with the Hochberg correction for
Assay (ELISA) multiple testing was used.79 The Mann–Whitney test with
The plasma levels of CRP were detected in diluted plasma the Hochberg correction for multiple testing was used to
samples (1:7000) using a DuoSet ELISA kit, while compare the effects of the two treatments – the MBSR
Quantikine HS ELISA Human TNFα Immunoassay and course and cognitive training. Statistical analysis was per
Human IL-6 Immunoassay were used to measure TNFα and formed using R and RStudio and the chosen significance
IL-6 in undiluted plasma samples. The ELISA assays were level was α = 0.05. For each test, the effect size was
used as recommended by the manufacturer (R&D Systems). calculated as the difference between two medians divided
Data acquisition was performed using a Multiskan GO by a pooled standard deviation of the data.
In the V3 analysis of the MBSR group, we also exam
For personal use only.
Table 1 Demographics and Test Performance at Baseline (Mean, SD) for MSBR (n=12) and Control (n=8) Group
Overall (n=20) MBSR (n=12) Control (n=8) Group Effect (p)
Age (range 57–91 y) Mean ± SD 74 ± 6.9 73.83 ± 7.04 74.25 ± 7.25 0.374
Gender (Female/Male) 13/7 6/6 7/1 0.213
Education years 14.3 ± 2.79 14.08 ± 3.08 14.63 ± 2.45 0.611
MMSE Mean ± SD 27.26 ± 1.63 26.82 ± 1.72 27.875 ± 1.36 0.302
GDS score Mean ± SD 4.9 ± 3.39 6 ± 3.19 3.25 ± 3.15 0.075
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
BAI score Mean ± SD 11.45 ± 11.22 14.92 ± 12.42 6.25 ± 6.92 0.053
Shalom Mean ± SD 36.7 ± 11.73 39.5 ± 10.03 32.5 ± 13.47 0.231
characteristics are presented in Table 1. The between-group differences (Table 4). Furthermore, we evaluated the effect
differences were not significant on the level of significance α of MBSR on plasma level of TNF-α, IL-6 and CRP. We
= 0.05. did not observe any significant differences between the
subjects either before or after MBSR intervention (data
Depressive Symptoms, Anxiety and not shown).
Cognition
The MSBR group showed a significant decrease in GDS Post-Intervention Practice and Spiritual
For personal use only.
DovePress
Table 2 Test Performance (Median, Interquartile Range) and Results for MBSR (n=12) and Control (n=8) Group, Obtained by One-Sample Wilcoxon Test
Baseline Visit 2 Visit 3 Visit 2 vs Baseline Visit 3 vs Baseline
Table 3 Results for MBSR (n=12) and Control (n=8) Between- to be helpful. Six subjects checked “unspecified” as one of
Group Comparison, Obtained by Mann–Whitney Test their reasons for not practicing at home.
MSBR vs Control Group In Figure 2, we present the adherence to home practice
Visit 2 vs Baseline Visit 3 vs Baseline
2a, the most and the least popular practices 2b, the most
appreciated aspects of MBSR 2c, and the challenging
p d p d
aspects of MBSR 2d.
Memory score 0.938 −0.124 0.847 −0.616 We also explored the influence of baseline levels of
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
a day. Participants reported meditating on average 5.1 (BAI <10) and high (BAI ≥ 10) anxiety levels, nor
days a week (SD 1.4). The most frequent reasons for not between subjects with low (GDS <6) and higher (GDS
practicing at home were not enough time, forgetting to do ≥ 6) depression levels in their adherence to meditation
the practice, the inability to concentrate or not believing it home practice.
Table 4 Changes in Imunophenotype (Mean, SD) for MSBR (n=12) and Control (n=8) Group, Obtained by One-Sample Wilcoxon
Test
Baseline Visit 2 (Mean Wilcoxon p-value Baseline Visit 2 (Mean Wilcoxon p-value
(Mean ± SD) ± SD) Test Value (Mean ± SD) ± SD) Test Value
% phagocyting cells 15.10 ± 6.82 14.58 ± 9.52 31.00 0.57 19.61 ± 7.13 16.51 ± 9.60 4.00 0.22
Monocyte subsets
Classical (%) 84.58 ± 4.33 80.14 ±5.72 8.00 0.05 82.21 ± 6.39 81.90 ± 6.49 7.00 1.00
Intermediate (%) 4.29 ± 2.05 5.43 ± 2.41 57.00 0.53 4.92 ± 2.50 4.45 ± 1.90 10.00 1.00
Non-classical (%) 5.05 ± 2.78 7.06 ± 3.74 67.50 0.08 6.50 ± 3.50 6.60 ± 2.37 13.00 1.00
Changes in activation of
monocyte subsets
MHC-II on classical (GMF) 442.00 ± 94.58 465.33 ± 90.98 50.50 0.39 466.83 ± 122.54 413.33 ± 99.63 4.00 0.22
MHC-II on intermediate 1203.67 ± 1262.08 ± 43.00 0.79 1349.0 ± 368.96 1363.83 ± 12.00 0.84
(GMF) 298.74 306.91 318.88
MHC-II on non-classical 608.33 ± 202.94 580.25 ± 27.00 0.38 692.33 ± 236.97 629.67 ± 5.00 0.31
(GMF) 168.65 190.19
CD86 on classical (GMF) 363.17 ± 39.15 290.83 ± 5.00 0.01 359.50 ± 51.27 318.33 ± 0.00 0.03
68.84 41.83
CD86 on intermediate (GMF) 562.08 ± 507.75 ± 12.00 0.03 535.50 ± 81.35 494.50 ± 79.41 1.00 0.06
118.49 124.79
CD86 on non-classical (GMF) 393.50 ± 117.62 357.17 ± 84.07 23.50 0.24 384.0 ± 100.02 371.17 ± 48.76 6.00 0.40
Plasma analysis
hsCRP (mg/l) 1.57 ± 1.65 1.49 ± 1.55 −11.00 0.63 1.72 ± 1.66 1.15 ± 1.62 −7.00 0.56
IL-6 (pg/mL) 1.57 ± 0.65 2.00 ± 1.31 24.00 0.32 2.40 ± 1.82 2.48 ± 2.86 2.00 0.95
TNF-α (pg/mL) 1.12 ± 0.32 1.29 ± 0.44 38.00 0.10 1.07 ± 0.38 1.02 ± 0.37 −20.00 0.20
Figure 2 Adherence to home practice (A), the most and the least popular practices (B), the most appreciated aspects of MBSR (C) and the challenging aspects of MBSR (D).
analysis did not focus directly on baseline, V2 or V3 scores, depression perform significantly slower than healthy
but was instead focused on their differences, this fact could controls,110,111 thus better psychomotor speed in our
have potentially highlighted the effect of MBSR on this study could be hypothetically connected to the improve
variable. We can hypothetically consider that if the mean ment of depressive symptoms in the MBSR group. It is
depressive symptom level in this group had been smaller, possible that some of the effects of MBSR could be uni
the effect of the intervention would also have been smaller. versally attributed to/mediated by the reduction of anxiety
Surprisingly, we did not observe any significant effect and depression.112
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
on anxiety level, although we could see a trend of Our preliminary results suggest that MBSR is not
decreased mean anxiety after MBSR intervention. This a program that can improve cognitive functions more
finding could be explained by the increased presence of rapidly compared to standard cognitive training.
physical difficulties in the elderly, which can be falsely However, the interpretation of these results does not neces
interpreted as increased anxiety by the BAI questionnaire sarily indicate the ineffectiveness of MBSR in this area, as
and therefore mantle the MBSR effect on pure anxiety the results are compared to active intervention.67 In this
symptoms.24 context, the observed MBSR effect on psychomotor speed
Based on previous studies, MBPs can have both a direct may be emphasized. Moreover, unlike cognitive training,
and indirect effect on cognitive performance. Indirectly, MBSR represents a more complex intervention, with an
MBPs can influence factors that can augment the likelihood effect on depressive symptoms and immunological vari
of hippocampal damage, such as stress, depression, and ables. There is a presumption that MBSR, like other mind
For personal use only.
metabolic syndrome.85 There are a few possible ways of fulness programs, can affect the pathophysiological
how MBPs can mediate reduced stress and depression. The pathways associated with AN neurodegeneration. Thus,
studies support the role MBPs play in the diminution of MBSR could potentially affect negative pathophysiologi
steroid hormones,86–90 decreasing systemic inflammation cal cascades and bring a longer-term effect with the same
through the regulation of cytokines91–94 and the restoration 8-week effort.113–115
of systemic levels of serotonin after inflammation Our results may be related to the findings of
reduction.95,96 Research on the contribution of MBPs on a systematic review that question the effect of MBSR on
metabolic syndrome control concerns their role in the cognition.116 In this review, there was no evidence of
reduction of inflammation,97 the restoration of normal oxi improvement in attention and executive function, although
dative status,98–104 the reduction of white matter hyperin there was preliminary evidence of improvement in work
tensities (WMH)85 and the increase of insulin sensitivity,105 ing memory, autobiographical memory and global pro
thus it focuses on how MBPs contribute to a brain main cesses, such as cognitive flexibility and meta-awareness.
tenance. Directly, MBPs such as MBSR could enhance The authors hypothesize that MBSR has more of
cognition through positive structural changes in brain struc a protective effect than an enhancing effect, and mind
tures relevant for memory,106,107 as well as building fulness seems to prevent further cognitive decline instead
a cognitive reserve through the repeated activation of atten of improving cognitive functions in the ageing population.
tional functions.108,109 This hypothesis seems to be confirmed in the empirical
In our study, we observed significantly improved psy field, where prolonged and adapted Mindfulness-Based
chomotor speed performance in the MBSR group com Programs have successfully slowed down cognitive
pared to the control group. These results are consistent decline in comparison to control and muscle relaxation
with a similar study resulting with non-significant effect groups.117
on cognition.39,49 However, the improvement in psycho The positive effect of MBSR on cognition reported in
motor speed shown in our study had not yet been reported, another study41 could draw attention to the need for
whereas other studies reported improvements in attention, MBSR to be adapted to the specific MCI population and
working memory and long-term memory40 or in cognitive the length of the intervention, as was done in the men
functions generally.41 Our results could be viewed with the tioned study.
fact that we used more sensitive tests suitable for the MCI Our data obtained from the feasibility questionnaires
population with a minimal learning effect (in contrast with suggested that MCI participants generally enjoyed the
global screening tests such as MoCA and MMSE used in MBSR intervention and were capable of keeping up with
other studies).41,49 Some studies suggest that patients with the rather intensive demands of home practice; this is also
consistent with the previously reported data.49 We think study. We therefore focused on changes in inflammatory
that one of the possible reasons behind weaker adherence cytokines and monocytes from peripheral blood.
to the practice in the third and fourth weeks might be due Here we report the change of activation status assessed
to the increased amount of home practice in these weeks. through the expression of CD86 in both the MBSR and
Our finding that participants with more severe cogni control groups at V2. These observations indeed need to
tive decline tended to adhere less to the recommended be confirmed by an analysis of other inflammatory mar
amount of home practice might be either due to worsened kers, the performance of functional tests in sorted mono
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
memory, and therefore the inability to remember to prac cyte subsets and including additional appropriate controls.
tice regularly, or problems in organizing one’s daily rou The relatively short 8-week interventions could
tine due to worsened executive functions and cognitive hypothetically be too short to influence cognitive func
disorganization. No notable changes in terms of adherence tions, which are less dynamic than mood disorders.
were found when comparing different levels of anxiety Although, in our study, we did not find any correlation
and depression, suggesting that these do not seem to play between the effect of MBSR and the number of post-
a dominant role in determining engagement with home intervention practice days. In contrast, the meta-analysis
practice in MCI patients. The participants’ responses also reports small but still significant association between
suggested that they tended to favor formal practice more MBSR home practice and intervention outcomes.120 It is
than informal. We think that since informal practice does possible that a longer intervention could have a positive
effect on cognitive functions, as some studies on healthy
not have the framework of clearly defined formal practice,
For personal use only.
effect of MBSR. It is therefore appropriate to consider answer the question about the protective potential of
adapting this method to these patients, specifically, sub MBSR due to the risk of developing AN.
jects with early MCI might be more adherent to the inter Future research and adaptations in this area may be
vention. Also, providing subjects with short audio guides inspired by other techniques based on meditation practice.
with instructions about home informal practice, e.g. mind Several studies have shown the positive effect of different
ful eating, might increase their adherence to the home meditation practices (Kirtan Kriya, Kundalini Yoga, etc.)
practice. The adaptation may also involve an extension on cognition and other variables of mental and physical
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
of time of the intervention - the results of other studies health in MCI and in the population with subjective mem
suggest that a longer than 8-week intervention period ory complaints.29−124−126
could support the expected intervention effect.41,117,121,122
At the MCI stage, it is often difficult to determine the Conclusions
etiology that causes cognitive deficit and various etiologies The findings of this study suggest that MBSR is generally
are typically associated with impairment in different cog well accepted by MCI subjects; however, cognitive decline
nitive domains.39 Therefore, another limitation is the pos might be negatively related to adherence to home practice
sible different etiologies due to a lack of biomarker and might require adjustments being made to the course.
evidence. Future research with clearly defined etiologies MBSR can decrease the level of depressive symptoms
over the long term, but it is not more effective than
could clarify the mechanism of MBSR and more precisely
standard cognitive training in the short term on general
define the population that can benefit from MBSR.
For personal use only.
17. Langa KM, Levine DA. The diagnosis and management of mild
References cognitive impairment: a clinical review. JAMA. 2014;312
(23):2551–2561. doi:10.1001/jama.2014.13806
1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The 18. Horrigan BJ. New studies support the therapeutic value of meditation.
global prevalence of dementia: a systematic review and Explore. 2007;3(5):449–452. doi:10.1016/j.explore.2007.07.003
metaanalysis. Alzheimers Dement. 2013;9(1):63–75. doi:10.10 19. Marciniak R, Sheardova K, Čermáková P, Hudeček D, Šumec R,
16/j.jalz.2012.11.007 Hort J. Effect of meditation on cognitive functions in context of
2. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild aging and neurodegenerative diseases. Front Behav Neurosci.
cognitive impairment due to alzheimer’s disease: recommendations 2014;8:17. doi:10.3389/fnbeh.2014.00017
from the National Institute on Aging-Alzheimer’s Association 20. Kurth F, Cherbuin N, Luders E. Reduced age-related degenera
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
workgroups on diagnostic guidelines for alzheimer’s disease. tion of the hippocampal subiculum in long-term meditators.
Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011. Psychiatry Res. 2015;232(3):214–218. doi:10.1016/j.pscychresns.
03.008 2015.03.008
3. Orgeta V, Qazi A, Spector A, Orrell M. Psychological treatments 21. Gard T, Hölzel BK, Lazar SW. The potential effects of meditation
for depression and anxiety in dementia and mild cognitive impair on age-related cognitive decline: a systematic review. Ann
ment: systematic review and meta-analysis. Br J Psychiat. N Y Acad Sci. 2014;1307:89. doi:10.1111/nyas.12348
2015;207(4):293–298. doi:10.1192/bjp.bp.114.148130 22. Tang YY, Hölzel BK, Posner MI. The neuroscience of mindfulness
4. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, meditation. Nat Rev Neurosci. 2015;16(4):213–225. doi:10.1038/
DeKosky S. Prevalence of neuropsychiatric symptoms in dementia nrn3916
and mild cognitive impairment: results from the cardiovascular 23. Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based
health study. JAMA. 2002;288(12):1475–1483. doi:10.1001/ cognitive therapy and mindfulness-based stress reduction improve men
jama.288.12.1475
tal health and wellbeing? A systematic review and meta-analysis of
5. Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL.
mediation studies. Clin Psychol Rev. 2015;37:1–2. doi:10.1016/j.
Donepezil delays progression to AD in MCI subjects with depressive
cpr.2015.01.006
symptoms. Neurology. 2009;72(24):2115–2121. doi:10.1212/
24. Hofmann SG, Gómez AF. Mindfulness-based interventions for
For personal use only.
WNL.0b013e3181aa52d3
anxiety and depression. Psychiatr Clin. 2017;40(4):739–749.
6. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging: an evolu
doi:10.1016/j.psc.2017.08.008
tionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908
25. Innes KE, Selfe TK, Brown CJ, Rose KM, Thompson-
(1):244–254. doi:10.1111/j.1749-6632.2000.tb06651.x
Heisterman A. The effects of meditation on perceived stress
7. Di Benedetto S, Müller L, Wenger E, Düzel S, Pawelec G.
and related indices of psychological status and sympathetic acti
Contribution of neuroinflammation and immunity to brain aging
vation in persons with alzheimer’s disease and their caregivers:
and the mitigating effects of physical and cognitive interventions.
a pilot study. Evid Based Complement Alternat Med. 2012;2012.
Neurosci Biobehav Rev. 2017;75:114–128. doi:10.1016/j.
neubiorev.2017.01.044 doi:10.1155/2012/927509
8. Michaud M, Balardy L, Moulis G, et al. Proinflammatory cyto 26. Khalsa DS, Ashford JW. Stress, meditation, and alzheimer’s dis
kines, aging, and age-related diseases. J Am Med Dir Assoc. ease prevention: where the evidence stands. J Alzheimers Dis.
2013;14(12):877–882. doi:10.1016/j.jamda.2013.05.009 2015;48(1):1–2. doi:10.3233/JAD-142766
9. Giunta B, Fernandez F, Nikolic WV, et al. Inflammaging as 27. Russell-Williams J, Jaroudi W, Perich T, Hoscheidt S, El Haj M,
a prodrome to alzheimer’s disease. J Neuroinflammation. 2008;5 Moustafa AA. Mindfulness and meditation: treating cognitive
(1):51. doi:10.1186/1742-2094-5-51 impairment and reducing stress in dementia. Rev Neurosci.
10. Tao Q, Ang TF, DeCarli C, et al. Association of chronic low-grade 2018;29(7):791–804. doi:10.1515/revneuro-2017-0066
inflammation with risk of alzheimer disease in ApoE4 carriers. JAMA 28. Newberg AB, Serruya M, Wintering N, Moss AS, Reibel D,
netw open. 2018;1(6):e183597. doi:10.1001/jamanetworkopen. Monti DA. Meditation and neurodegenerative diseases. Ann
2018.3597 N Y Acad Sci. 2014;1307(1):112–123. doi:10.1111/nyas.12187
11. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory pro 29. Newberg AB, Wintering N, Khalsa DS, Roggenkamp H,
cess in alzheimer’s disease, role of cytokines. Sci World J. Waldman MR. Meditation effects on cognitive function and cere
2012;2012. bral blood flow in subjects with memory loss: a preliminary study.
12. Le Page A, Garneau H, Dupuis G, et al. Differential phenotypes of J Alzheimers Dis. 2010;20(2):517–526. doi:10.3233/JAD-2010-
myeloid-derived suppressor and T regulatory cells and cytokine 1391
levels in amnestic mild cognitive impairment subjects compared 30. Grant JA, Courtemanche J, Duerden EG, Duncan GH, Rainville P.
to mild alzheimer diseased patients. Front Immunol. 2017;8:783. Cortical thickness and pain sensitivity in zen meditators. Emotion.
doi:10.3389/fimmu.2017.00783 2010;10(1):43. doi:10.1037/a0018334
13. Le Page A, Lamoureux J, Bourgade K, et al. Polymorphonuclear 31. Luders E, Clark K, Narr KL, Toga AW. Enhanced brain connectiv
neutrophil functions are differentially altered in amnestic mild ity in long-term meditation practitioners. Neuroimage. 2011;57
cognitive impairment and mild alzheimer’s disease patients. (4):1308–1316. doi:10.1016/j.neuroimage.2011.05.075
Journal of Alzheimer’s Disease. 2017;60(1):23–42. doi:10.3233/ 32. Wells RE, Yeh GY, Kerr CE, et al. Meditation’s impact on default
JAD-170124 mode network and hippocampus in mild cognitive impairment:
14. Griciuc A, Serrano-Pozo A, Parrado AR, et al. Alzheimer’s disease a pilot study. Neurosci Lett. 2013;556:15–19. doi:10.1016/j.
risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. neulet.2013.10.001
2013;78(4):631–643. doi:10.1016/j.neuron.2013.04.014 33. Kabat-Zinn J. Full Catastrophe Living, Revised Edition: How to Cope
15. Bradshaw EM, Chibnik LB, Keenan BT, et al. CD33 alzheimer’s with Stress, Pain and Illness Using Mindfulness Meditation. Hachette
disease locus: altered monocyte function and amyloid biology. Nat UK; 2013.
Neurosci. 2013;16(7):848–850. doi:10.1038/nn.3435 34. Kabat-Zinn J. Wherever You Go, There You Are: Mindfulness
16. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Meditation in Everyday Life. Hachette Books; 2009.
Kokmen E. Mild cognitive impairment: clinical characterization 35. Crane RS. Implementing mindfulness in the mainstream: making
and outcome. Arch Neurol. 1999;56(3):303–308. doi:10.1001/ the path by walking it. Mindfulness. 2017;8(3):585–594.
archneur.56.3.303 doi:10.1007/s12671-016-0632-7
36. Moss AS, Reibel DK, Greeson JM, et al. An adapted mindfulness-based 53. Greeson JM, Webber DM, Smoski MJ, et al. Changes in spirituality
stress reduction program for elders in a continuing care retirement partly explain health-related quality of life outcomes after
community: quantitative and qualitative results from a pilot randomized mindfulness-based stress reduction. J Behav Med. 2011;34
controlled trial. J Appl Gerontol. 2015;34(4):518–538. doi:10.1177/ (6):508–518. doi:10.1007/s10865-011-9332-x
0733464814559411 54. Carmody J, Baer RA. Relationships between mindfulness practice
37. Creswell JD, Irwin MR, Burklund LJ, et al. Mindfulness-based and levels of mindfulness, medical and psychological symptoms
stress reduction training reduces loneliness and pro-inflammatory and well-being in a mindfulness-based stress reduction program.
gene expression in older adults: a small randomized controlled trial. J Behav Med. 2008;31(1):23–33. doi:10.1007/s10865-007-9130-7
Brain Behav Immun. 2012;26(7):1095–1101. doi:10.1016/j. 55. Birnie K, Speca M, Carlson LE. Exploring self-compassion and
bbi.2012.07.006 empathy in the context of mindfulness-based stress reduction
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
38. Ernst S, Welke J, Heintze C, et al. Effects of mindfulness-based (MBSR). Stress Health. 2010;26(5):359–371. doi:10.1002/
stress reduction on quality of life in nursing home residents: smi.1305
a feasibility study. Complement Med Res. 2008;15(2):74–81. 56. Moss AS, Wintering N, Roggenkamp H, et al. Effects of an 8-week
doi:10.1159/000121479 meditation program on mood and anxiety in patients with memory
39. Larouche E, Hudon C, Goulet S. Mindfulness mechanisms and psy loss. J Altern Complement Med. 2012;18(1):48–53. doi:10.1089/
chological effects for aMCI patients: a comparison with acm.2011.0051
psychoeducation. Complement Ther Clin Pract. 2019;34:93–104. 57. Kaufman Y, Anaki D, Binns M, Freedman M. Cognitive decline in
doi:10.1016/j.ctcp.2018.11.008 alzheimer disease: impact of spirituality, religiosity, and QOL.
40. Siang-Ted K, Fam J, Feng L, et al. Mindfulness modulates biomarkers Neurology. 2007;68(18):1509–1514. doi:10.1212/01.wnl.000026
and cognition in elderly with mild cognitive impairment (MCI): 0697.66617.59
a randomized controlled trial (RCT). Psychoneuroendocrinology. 58. Hosseini S, Chaurasia A, Oremus M. The effect of religion and
2017;83:46. doi:10.1016/j.psyneuen.2017.07.363 spirituality on cognitive function: a systematic review.
41. Wong WP, Coles J, Chambers R, Wu DB, Hassed C. The effects of Gerontologist. 2019;59(2):76–85. doi:10.1093/geront/gnx024
mindfulness on older adults with mild cognitive impairment. 59. Coin A, Perissinotto E, Najjar M, et al. Does religiosity protect against
J Alzheimers Dis Rep. 2017;1(1):181–193. doi:10.3233/ADR-
For personal use only.
69. Suchá J. Skupinové hry pro cvičení paměti v každém věku. Portál; 87. Matousek RH, Pruessner JC, Dobkin PL. Changes in the cortisol
2012. awakening response (CAR) following participation in
70. Bílková J. Kognitivní Trénink pro třetí věk: 100 cvičení pro rozvoj mindfulness-based stress reduction in women who completed treat
koncentrace, kreativity, paměti a verbálních dovedností. Grada; ment for breast cancer. Complement Ther Clin Pract. 2011;17
2016. (2):65–70. doi:10.1016/j.ctcp.2010.10.005
71. Bezdicek O, Lukavsky J, Stepankova H, et al. The Prague Stroop 88. Bränström R, Kvillemo P, Åkerstedt T. Effects of mindfulness
test: normative standards in older Czech adults and discriminative training on levels of cortisol in cancer patients. Psychosomatics.
validity for mild cognitive impairment in Parkinson’s disease. 2013;54(2):158–164. doi:10.1016/j.psym.2012.04.007
J Clin Exp Neuropsychol. 2015;37(8):794–807. doi:10.1080/ 89. Carlson LE, Doll R, Stephen J, et al. Randomized controlled trial
13803395.2015.1057106 of mindfulness-based cancer recovery versus supportive expres
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
72. Bezdicek O, Libon DJ, Stepankova H, et al. Development, validity, sive group therapy for distressed survivors of breast cancer.
and normative data study for the 12-word Philadelphia verbal J Clin Oncol. 2013;31(25):3119–3126. doi:10.1200/JCO.
learning test [czP (r) VLT-12] among older and very old Czech 2012.47.5210
adults. Clin Neuropsychol. 2014;28(7):1162–1181. doi:10.1080/ 90. Marcus MT, Fine PM, Moeller FG, et al. Change in stress levels
13854046.2014.952666 following mindfulness-based stress reduction in a therapeutic
73. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age community. Addict Disord Their Treat. 2003;2(3):63–68.
and education for two measures of verbal fluency: FAS and animal doi:10.1097/00132576-200302030-00001
naming. Arch Clin Neuropsychol. 1999;14(2):167–177. 91. Kox M, Stoffels M, Smeekens SP, et al. The influence of concen
74. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent tration/meditation on autonomic nervous system activity and the
evidence and development of a shorter version. Clin Gerontol. 1986. innate immune response: a case study. Psychosom Med. 2012;74
75. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measur (5):489–494. doi:10.1097/PSY.0b013e3182583c6d
ing clinical anxiety: psychometric properties. J Consult Clin 92. Rosenkranz MA, Davidson RJ, MacCoon DG, Sheridan JF,
Psychol. 1988;56(6):893. doi:10.1037/0022-006X.56.6.893 Kalin NH, Lutz A. A comparison of mindfulness-based stress
76. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of reduction and an active control in modulation of neurogenic
monocytes and dendritic cells in blood. Blood. 2010;116(16):e74– inflammation. Brain Behav Immun. 2013;27:174–184. doi:10.
For personal use only.
104. Martarelli D, Cocchioni M, Scuri S, Pompei P. Diaphragmatic breath 116. Lao SA, Kissane D, Meadows G. Cognitive effects of MBSR/MBCT:
ing reduces postprandial oxidative stress. J Altern Complement Med. a systematic review of neuropsychological outcomes. Conscious
2011;17(7):623–628. doi:10.1089/acm.2010.0666 Cogn. 2016;45:109–123. doi:10.1016/j.concog.2016.08.017
105. Gallegos AM, Hoerger M, Talbot NL, et al. Toward identifying the 117. Quintana-Hernandez DJ, Miro-Barrachina MT, Ibanez-Fernandez
effects of the specific components of mindfulness-based stress IJ, et al. Mindfulness in the maintenance of cognitive capacities
reduction on biologic and emotional outcomes among older in alzheimer’s disease: a randomized clinical trial. J Alzheimers
adults. J Altern Complement Med. 2013;19(10):787–792. doi:10. Dis. 2016;50(1):217–232. doi:10.3233/JAD-143009
1089/acm.2012.0028 118. Bower JE, Crosswell AD, Stanton AL, et al. Mindfulness medita
106. Hölzel BK, Carmody J, Vangel M, et al. Mindfulness practice leads tion for younger breast cancer survivors: a randomized controlled
to increases in regional brain gray matter density. Psychiatry Res. trial. Cancer. 2015;121(8):1231–1240. doi:10.1002/cncr.29194
Clinical Interventions in Aging downloaded from https://www.dovepress.com/ by 193.202.81.159 on 16-Aug-2020
2011;191(1):36–43. doi:10.1016/j.pscychresns.2010.08.006 119. Malarkey WB, Jarjoura D, Klatt M. Workplace based mindfulness
107. Fox KC, Nijeboer S, Dixon ML, et al. Is meditation associated with practice and inflammation: a randomized trial. Brain Behav Immun.
altered brain structure? A systematic review and meta-analysis of 2013;27:145–154. doi:10.1016/j.bbi.2012.10.009
morphometric neuroimaging in meditation practitioners. Neurosci 120. Parsons CE, Crane C, Parsons LJ, Fjorback LO, Kuyken W. Home
Biobehav Rev. 2014;43:48–73. doi:10.1016/j.neubiorev.2014.03.016 practice in mindfulness-based cognitive therapy and mindfulness-
108. Malinowski P. Neural mechanisms of attentional control in mind based stress reduction: a systematic review and meta-analysis of
fulness meditation. Front Neurosci. 2013;7:8. doi:10.3389/ participants’ mindfulness practice and its association with outcomes.
fnins.2013.00008 Behav Res Ther. 2017;95:29–41. doi:10.1016/j.brat.2017.05.004
109. Malinowski P, Shalamanova L. Meditation and cognitive ageing: 121. Alexander C, Langer E, Newman R, Chandler H, Davies J. Aging,
the role of mindfulness meditation in building cognitive reserve. mindfulness and meditation. J Pers Soc Psychol. 1989;57:950–964.
Journal of Cognitive Enhancement. 2017;1(2):96–106. doi:10.1037/0022-3514.57.6.950
doi:10.1007/s41465-017-0022-7 122. Prakash R, Rastogi P, Dubey I, Abhishek P, Chaudhury S,
110. Kertzman S, Reznik I, Hornik-Lurie T, Weizman A, Kotler M, Small BJ. Long-term concentrative meditation and cognitive per
Amital D. Stroop performance in major depression: selective atten formance among older adults. Aging Neuropsycholo Cognition.
tion impairment or psychomotor slowness? J Affect Disord.
For personal use only.
2012;19(4):479–494. doi:10.1080/13825585.2011.630932
2010;122(1–2):167–173. doi:10.1016/j.jad.2009.08.009
123. Pérez-Aranda A, Feliu-Soler A, Montero-Marín J, et al.
111. Rosenberg PB, Mielke MM, Xue QL, Carlson MC. Depressive
A randomized controlled efficacy trial of mindfulness-based stress
symptoms predict incident cognitive impairment in cognitive
reduction compared with an active control group and usual care for
healthy older women. Am J Geriatr Psychiatry. 2010;18
fibromyalgia: the EUDAIMON study. Pain. 2019;160
(3):204–211. doi:10.1097/JGP.0b013e3181c53487
(11):2508–2523. doi:10.1097/j.pain.0000000000001655
112. Feliu-Soler A, Pérez-Aranda A, Andrés-Rodríguez L, et al. Digging
124. Eyre HA, Siddarth P, Acevedo B, et al. A randomized controlled trial
into the construct of fibrofog: psychometric properties of the
of Kundalini yoga in mild cognitive impairment. Int Psychogeriatr.
Spanish version of the multidimensional inventory of subjective
2017;29(4):557–567. doi:10.1017/S1041610216002155
cognitive impairment in patients with fibromyalgia. J Appl
125. Innes KE, Selfe TK, Brundage K, et al. Effects of meditation and
Biobehav Res. 2018;23(2):12134. doi:10.1111/jabr.12134
music-listening on blood biomarkers of cellular aging and alzhei
113. Gilbertson MW, Shenton ME, Ciszewski A, et al. Smaller hippo
campal volume predicts pathologic vulnerability to psychological mer’s disease in adults with subjective cognitive decline: an
trauma. Nat Neurosci. 2002;5(11):1242–1247. doi:10.1038/nn958 exploratory randomized clinical trial. J Alzheimers Dis. 2018;66
114. Wager-Smith K, Markou A. Depression: a repair response to (3):947–970. doi:10.3233/JAD-180164
stress-induced neuronal microdamage that can grade into 126. Innes KE, Selfe TK, Khalsa DS, Kandati S, Ashford JW.
a chronic neuroinflammatory condition? Neurosci Biobehav Rev. Meditation and music improve memory and cognitive function in
2011;35(3):742–764. doi:10.1016/j.neubiorev.2010.09.010 adults with subjective cognitive decline: a pilot randomized con
115. Heneka MT, O’Banion MK, Terwel D, Kummer MP. trolled trial. J Alzheimers Dis. 2017;56(3):899–916. doi:10.3233/
Neuroinflammatory processes in alzheimer’s disease. J Neural JAD-160867
Transm. 2010;117(8):919–947.